Taste disorders in myasthenia gravis

A multicenter cooperative study

C. Kabasawa, Y. Shimizu, Shigeaki Suzuki, M. Masuda, Y. Nagane, K. Utsugisawa, Y. Suzuki, H. Utsumi, K. Fujihara, N. Suzuki, S. Uchiyama

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background and purpose: The purpose of the present study was to investigate the prevalence and clinical characteristics of taste disorders in patients with myasthenia gravis (MG). Methods: We studied 371 Japanese patients with MG (127 men and 244 women; mean age, 56.6±16.9years) consecutively evaluated between May and September 2010 in six neurological centers comprising the East Japan MG Study Group. Ninety-three patients (25%) had thymoma. We interviewed all patients to determine whether they had taste disorders during the clinical course of MG and then further evaluated the patients with MG, who reported having taste disorders, using a questionnaire. Results: Taste disorders were observed in 16 (4.3%) of the 371 patients with MG. We concluded that taste disorders in 2.4% of patients with MG excluding other factors were associated with MG itself. All patients had thymoma with seropositivity for anti-acetylcholine receptor antibodies. Thymoma tended to be advanced, and four patients with Masaoka stage IVa required radiation therapy or chemotherapy. Five patients noticed taste disorders 2-3months before the onset of MG. Sweet taste loss was more common than salty, bitter, and sour taste loss. Conclusions: This was the first systematic survey of taste disorders in patients with MG by a multicenter study. Taste disorders were more common in the present sample of patients with MG than in the general population.

Original languageEnglish
Pages (from-to)205-207
Number of pages3
JournalEuropean Journal of Neurology
Volume20
Issue number1
DOIs
Publication statusPublished - 2013 Jan

Fingerprint

Taste Disorders
Myasthenia Gravis
Multicenter Studies
Thymoma
Cholinergic Receptors

Keywords

  • Myasthenia gravis
  • Sweet taste
  • Taste disorder
  • Thymoma

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Kabasawa, C., Shimizu, Y., Suzuki, S., Masuda, M., Nagane, Y., Utsugisawa, K., ... Uchiyama, S. (2013). Taste disorders in myasthenia gravis: A multicenter cooperative study. European Journal of Neurology, 20(1), 205-207. https://doi.org/10.1111/j.1468-1331.2012.03713.x

Taste disorders in myasthenia gravis : A multicenter cooperative study. / Kabasawa, C.; Shimizu, Y.; Suzuki, Shigeaki; Masuda, M.; Nagane, Y.; Utsugisawa, K.; Suzuki, Y.; Utsumi, H.; Fujihara, K.; Suzuki, N.; Uchiyama, S.

In: European Journal of Neurology, Vol. 20, No. 1, 01.2013, p. 205-207.

Research output: Contribution to journalArticle

Kabasawa, C, Shimizu, Y, Suzuki, S, Masuda, M, Nagane, Y, Utsugisawa, K, Suzuki, Y, Utsumi, H, Fujihara, K, Suzuki, N & Uchiyama, S 2013, 'Taste disorders in myasthenia gravis: A multicenter cooperative study', European Journal of Neurology, vol. 20, no. 1, pp. 205-207. https://doi.org/10.1111/j.1468-1331.2012.03713.x
Kabasawa, C. ; Shimizu, Y. ; Suzuki, Shigeaki ; Masuda, M. ; Nagane, Y. ; Utsugisawa, K. ; Suzuki, Y. ; Utsumi, H. ; Fujihara, K. ; Suzuki, N. ; Uchiyama, S. / Taste disorders in myasthenia gravis : A multicenter cooperative study. In: European Journal of Neurology. 2013 ; Vol. 20, No. 1. pp. 205-207.
@article{a8ac1cfec6fb4a7db7bd42129eb708e5,
title = "Taste disorders in myasthenia gravis: A multicenter cooperative study",
abstract = "Background and purpose: The purpose of the present study was to investigate the prevalence and clinical characteristics of taste disorders in patients with myasthenia gravis (MG). Methods: We studied 371 Japanese patients with MG (127 men and 244 women; mean age, 56.6±16.9years) consecutively evaluated between May and September 2010 in six neurological centers comprising the East Japan MG Study Group. Ninety-three patients (25{\%}) had thymoma. We interviewed all patients to determine whether they had taste disorders during the clinical course of MG and then further evaluated the patients with MG, who reported having taste disorders, using a questionnaire. Results: Taste disorders were observed in 16 (4.3{\%}) of the 371 patients with MG. We concluded that taste disorders in 2.4{\%} of patients with MG excluding other factors were associated with MG itself. All patients had thymoma with seropositivity for anti-acetylcholine receptor antibodies. Thymoma tended to be advanced, and four patients with Masaoka stage IVa required radiation therapy or chemotherapy. Five patients noticed taste disorders 2-3months before the onset of MG. Sweet taste loss was more common than salty, bitter, and sour taste loss. Conclusions: This was the first systematic survey of taste disorders in patients with MG by a multicenter study. Taste disorders were more common in the present sample of patients with MG than in the general population.",
keywords = "Myasthenia gravis, Sweet taste, Taste disorder, Thymoma",
author = "C. Kabasawa and Y. Shimizu and Shigeaki Suzuki and M. Masuda and Y. Nagane and K. Utsugisawa and Y. Suzuki and H. Utsumi and K. Fujihara and N. Suzuki and S. Uchiyama",
year = "2013",
month = "1",
doi = "10.1111/j.1468-1331.2012.03713.x",
language = "English",
volume = "20",
pages = "205--207",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Taste disorders in myasthenia gravis

T2 - A multicenter cooperative study

AU - Kabasawa, C.

AU - Shimizu, Y.

AU - Suzuki, Shigeaki

AU - Masuda, M.

AU - Nagane, Y.

AU - Utsugisawa, K.

AU - Suzuki, Y.

AU - Utsumi, H.

AU - Fujihara, K.

AU - Suzuki, N.

AU - Uchiyama, S.

PY - 2013/1

Y1 - 2013/1

N2 - Background and purpose: The purpose of the present study was to investigate the prevalence and clinical characteristics of taste disorders in patients with myasthenia gravis (MG). Methods: We studied 371 Japanese patients with MG (127 men and 244 women; mean age, 56.6±16.9years) consecutively evaluated between May and September 2010 in six neurological centers comprising the East Japan MG Study Group. Ninety-three patients (25%) had thymoma. We interviewed all patients to determine whether they had taste disorders during the clinical course of MG and then further evaluated the patients with MG, who reported having taste disorders, using a questionnaire. Results: Taste disorders were observed in 16 (4.3%) of the 371 patients with MG. We concluded that taste disorders in 2.4% of patients with MG excluding other factors were associated with MG itself. All patients had thymoma with seropositivity for anti-acetylcholine receptor antibodies. Thymoma tended to be advanced, and four patients with Masaoka stage IVa required radiation therapy or chemotherapy. Five patients noticed taste disorders 2-3months before the onset of MG. Sweet taste loss was more common than salty, bitter, and sour taste loss. Conclusions: This was the first systematic survey of taste disorders in patients with MG by a multicenter study. Taste disorders were more common in the present sample of patients with MG than in the general population.

AB - Background and purpose: The purpose of the present study was to investigate the prevalence and clinical characteristics of taste disorders in patients with myasthenia gravis (MG). Methods: We studied 371 Japanese patients with MG (127 men and 244 women; mean age, 56.6±16.9years) consecutively evaluated between May and September 2010 in six neurological centers comprising the East Japan MG Study Group. Ninety-three patients (25%) had thymoma. We interviewed all patients to determine whether they had taste disorders during the clinical course of MG and then further evaluated the patients with MG, who reported having taste disorders, using a questionnaire. Results: Taste disorders were observed in 16 (4.3%) of the 371 patients with MG. We concluded that taste disorders in 2.4% of patients with MG excluding other factors were associated with MG itself. All patients had thymoma with seropositivity for anti-acetylcholine receptor antibodies. Thymoma tended to be advanced, and four patients with Masaoka stage IVa required radiation therapy or chemotherapy. Five patients noticed taste disorders 2-3months before the onset of MG. Sweet taste loss was more common than salty, bitter, and sour taste loss. Conclusions: This was the first systematic survey of taste disorders in patients with MG by a multicenter study. Taste disorders were more common in the present sample of patients with MG than in the general population.

KW - Myasthenia gravis

KW - Sweet taste

KW - Taste disorder

KW - Thymoma

UR - http://www.scopus.com/inward/record.url?scp=84871652859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871652859&partnerID=8YFLogxK

U2 - 10.1111/j.1468-1331.2012.03713.x

DO - 10.1111/j.1468-1331.2012.03713.x

M3 - Article

VL - 20

SP - 205

EP - 207

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 1

ER -